Skip to main content

Table 3 Comparison of the three periods (time-stratified data)

From: The impact of continuous renal replacement therapy on renal outcomes in dialysis-requiring acute kidney injury may be related to the baseline kidney function

 

Evaluated periods

P

1999–2003

2004–2008

2009–2012

AKI N (incidence-%)

271 (2.56%)

588 (4.77%)

634 (5.17%)

0.001

Liver disease and liver transplant N (%)

 Cirrhosis/other liver diseases

21

7.70%

27

4.60%

52

8.20%

<0.001

 Liver transplant

52

19.20%

197

33.50%

261

41.20%

Heart disease N (%)

94

34.70%

228

38.80%

206

32.50%

0.069

Malignant solid tumor N (%)

42

15.50%

78

13.30%

80

12.60%

0.504

Solid organ transplant N (%)

52

19.20%

200

34.00%

274

43.20%

<0.001

Hematologic malignances and BMT N (%)

19

7.00%

46

7.80%

42

6.60%

0.715

Sepsis-AKI N (%)

148

54.60%

329

56.00%

362

57.10%

0.779

RRT modality N (%)

 Hemodialysis

97

35.80%

228

38.80%

176

27.80%

<0.001

 Continuous dialysis

174

64.20%

360

61.20%

458

72.20%

Outcomes N (%)

 Death

158

58.30%

312

53.10%

335

52.80%

0.352

 Dialysis dependence

26

9.60%

81

13.80%

77

12.10%

 Recovery of renal function

87

32.10%

195

33.20%

222

35.00%

Vasopressors N (%)

257

94.80%

558

94.90%

593

93.50%

0.541

Mechanical ventilation N (%)

231

85.20%

502

85.40%

544

85.80%

0.966

APACHE II score median (IQR)

20

(19–22)

25

(18–29)

26

(18–31)

<0.001

Age (years) mean (SD)

64

18

65

18

61

18

<0.001

  1. AKI acute kidney injury, BMT bone marrow transplantation, RRT renal replacement therapy, APACHE Acute Physiology And Chronic Health Evaluation, SD standard deviation, IQR, interquartile range